ERIS.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 18:00):

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology...

Stats
今日成交量	68 982.00
平均成交量	179 937
市值	118.52B
EPS	INR0 ( 2024-02-13 )
下一个收益日期	( INR0 ) 2024-05-14
Last Dividend	INR7.35 ( 2022-08-11 )
Next Dividend	INR0 ( N/A )
P/E	30.73
ATR14	INR0.765 (0.09%)

音量相关性

長: 0.06 (neutral)

短: 0.61 (weak)

Signal:(45.397) Neutral

Eris Lifesciences Limited 相关性

10 最正相关
NECCLTD.NS	0.892
BINDALAGRO.NS	0.889
ROSSARI.NS	0.887
SETFNIF50.NS	0.882
AXISNIFTY.NS	0.881
INDIANHUME.NS	0.881
KOTAKNIFTY.NS	0.88
ICICINIFTY.NS	0.879
LICNFNHGP.NS	0.879
BSLNIFTY.NS	0.878

10 最负相关
SOMATEX.NS	-0.88
JSL.NS	-0.873
4THDIM.NS	-0.859
KARDA.NS	-0.839
BSELINFRA.NS	-0.83
ISMTLTD.NS	-0.819
GAIL.NS	-0.817
KIRLFER.NS	-0.815
FOSECOIND.NS	-0.809
TARMAT.NS	-0.804

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Eris Lifesciences Limited 相关性 - 货币/商品

-0.08
( neutral )

-0.02
( neutral )

-0.18
( neutral )

0.05
( neutral )

0.40
( neutral )

0.00
( neutral )

Eris Lifesciences Limited 财务报表

Annual	2022
营收:	INR16.62B
毛利润:	INR13.09B (78.80 %)
EPS:	INR28.10

FY	2022
营收:	INR16.62B
毛利润:	INR13.09B (78.80 %)
EPS:	INR28.10

FY	2022
营收:	INR13.26B
毛利润:	INR10.65B (80.33 %)
EPS:	INR29.89

FY	2021
营收:	INR11.93B
毛利润:	INR9.51B (79.72 %)
EPS:	INR26.16

Financial Reports:

No articles found.

Eris Lifesciences Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR7.35 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Eris Lifesciences Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.44 - low (14.40%) | Divividend Growth Potential Score: 5.04 - Potential for dividend initiation, but uncertain (0.75%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.87	2020-03-19
Last Dividend	INR7.35	2022-08-11
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR21.73	--
Avg. Dividend % Per Year	0.44%	--
Score	1.99	--
Div. Sustainability Score	3.44
Div.Growth Potential Score	5.04
Div. Directional Score	4.24	--

Next Divdend (Est)
(2024-10-30)

INR0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.99

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR8.37	1.69%
2021	INR6.01	1.02%
2022	INR7.35	0.96%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RAYMOND.NS	Dividend Junior	2023-06-23	Sporadic	29	0.15%
KOTARISUG.NS	Dividend Junior	2023-08-03	Sporadic	11	0.58%
EVERESTIND.NS	Dividend Junior	2023-08-14	Annually	22	0.75%
AMBIKCO.NS	Dividend Junior	2023-09-22	Annually	17	1.61%
SYRMA.NS	No Dividend Player	2023-09-01	Insufficient data to determine frequency	2	0.18%
NEWGEN.NS	Dividend Knight	2023-06-20	Annually	7	2.26%
IFGLEXPOR.NS	Dividend Junior	2023-08-17	Annually	21	1.57%
CHAMBLFERT.NS	Dividend Junior	2023-08-21	Annually	23	1.58%
SAGCEM.NS	Dividend Junior	2023-06-20	Annually	18	0.28%
LTIM.NS	Dividend Knight	2023-07-10	Semi-Annually	9	0.87%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.210	1.500	5.80	8.70	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.167	1.500	9.26	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	8.08	1.000	8.12	8.12	[3 - 30]
operatingCashFlowPerShareTTM	19.15	2.00	3.62	7.23	[0 - 30]
freeCashFlowPerShareTTM	19.15	2.00	0.424	0.847	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.818	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.266	1.000	6.67	6.67	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.44

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.19	1.000	6.95	0	[1 - 100]
returnOnEquityTTM	0.167	2.50	9.52	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	19.15	2.00	3.62	0.847	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	19.15	2.00	3.62	7.23	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.19	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.142	1.000	8.96	0	[0.1 - 0.5]
Total Score				5.04

Eris Lifesciences Limited